Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 with Dr. Robert Terkeltaub.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

References & Resources
A list of key studies, abstracts, and materials featured in the activity.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Managing uncontrolled gout isn’t always straightforward—especially when flares persist, comorbidities complicate care, or standard therapies fall short. As our understanding of gout expands beyond just elevated uric acid, clinicians are being asked to think differently, integrating immune pathways, real-world evidence, and emerging treatments into everyday practice.

From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026, this CME-accredited podcast explores how to approach these complex cases with greater clarity and confidence. Featuring expert insights and the latest clinical evidence, each episode dives into practical strategies across the continuum of gout care.

Listeners will hear discussions on advances in uricase-based therapies, selective URAT1 inhibitors, and inflammation-targeted treatments, along with key considerations around safety, sequencing, and collaborative care. Through real-world examples and focused conversations, this series equips clinicians with actionable tools to personalize treatment, address therapeutic challenges, and improve long-term outcomes for patients living with uncontrolled gout.

Activity Summary:
Adult hemophagocytic lymphohistiocytosis (HLH) is increasingly recognized as part of a broader hyperinflammatory spectrum, yet early identification and management remain challenging in routine clinical practice. Many adult patients present with nonspecific symptoms that overlap with sepsis, malignancy-associated inflammation, or autoimmune disease, which can delay recognition and treatment.

Through real-world case discussions, live polling, and expert dialogue, this live webcast will strengthen the ability to recognize HLH across diverse clinical settings, integrate biomarkers and prognostic indicators into clinical decision-making, and apply adult-specific management strategies, including emerging therapeutic options.

Activity Summary:
To further build on the insights presented in the Clinical Clips® from EASL Congress 2026: Key Breakthroughs in the Treatment of PBC by Dr. Kris Kowdley, HCPs can access a range of downloadable resources designed to reinforce key concepts and support practical application in clinical care.

Available Resources:

Downloadable Slide Deck (PDF)
Downloadable version of the presentation slides used by the faculty, including data visuals, figures, and key discussion points.

Expert Commentary Transcript
A transcript of the podcast version of the program, reflecting the expert discussion and interpretation of EASL 2026 data.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.

Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.

Activity Summary:
Managing uncontrolled gout can be challenging, especially when patients continue to flare, struggle with comorbidities, or fail to respond as expected to standard therapy. As the understanding of gout evolves beyond hyperuricemia alone, clinicians are increasingly called upon to integrate immune mechanisms, real-world evidence, and new treatment options into everyday decision-making. Staying current requires not only awareness of emerging data, but also clarity on how to apply it in complex, real-world patients.

From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 is a CME-accredited educational program designed to help clinicians navigate these challenges with confidence. This program brings together expert perspectives, recent clinical evidence, and practical insights across the continuum of gout care. Learners will explore advances in uricase-based therapies, selective URAT1 inhibitors, and inflammation-targeted approaches, while also addressing safety, sequencing, and multidisciplinary coordination. Through focused discussion and clinically relevant examples, participants will gain actionable strategies to personalize care, overcome treatment inertia, and improve long-term management for patients living with uncontrolled gout.

Activity Summary:
These videos provide a concise overview of the latest clinical developments in Primary Biliary Cholangitis presented at EASL Congress 2026. Expert faculty discuss emerging evidence that is shaping the evolving treatment landscape and what these updates may mean for clinical practice.

Watch to gain practical insights into applying the newest data to personalized patient management, with the goal of improving outcomes and advancing the quality of care for individuals living with PBC.

Activity Summary:
To further expand knowledge from the Clinical Clips® in PAH: Conference Highlights, presented by Dr. Vallerie McLaughlin, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Summary Resource
Concise, one-page summary highlighting the most clinically relevant PAH studies and late-breaking presentations discussed in the Clinical Clip.

Downloadable Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from Echo's, Algorithms, and the Art of ILD-PH Detection presented by Dr. Steven Nathan, HCPs can access downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Available Resources:

Downloadable Slides
Downloadable PDF presentation slides, including data, visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the video/podcast for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from the HCM: Translating Cases into Care presented by Drs. Theodore Abraham and Martin Maron, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Downloadable Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

FAQs
A curated set of frequently asked questions addressing key clinical considerations, designed to support informed decision-making.

Reference and Resource Links
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Despite progress in disease identification and treatment strategies, PAH continues to carry considerable morbidity and mortality, highlighting the need for continued optimization of disease management.

Throughout this educational podcast, Dr. Vallerie McLaughlin highlights the latest advances in PAH presented at the International 2026 Conference in Orlando, FL.

Activity Summary:
Despite advances in disease recognition and therapeutic options, PAH remains associated with significant morbidity and mortality, underscoring the importance of optimizing disease management.

Throughout this Clinical Clip, Dr. Vallerie McLaughlin reviews the study design, patient populations, clinical endpoints, efficacy outcomes, and safety findings of selected high-impact research presented in Orlando, Florida May 15-20 at the International 2026 Conference.

Activity Summary:
Hypertrophic Cardiomyopathy (HCM) is often missed or inconsistently treated despite progress in diagnostic tools and treatment options. Clinicians frequently encounter difficulties with early identification, distinguishing HCM from similar conditions, and implementing evolving approaches to risk stratification and therapy.

In this three-part podcast series, Drs. Theodore Abraham and Martin Maron highlight practical approaches for better recognition, diagnosis, and management of HCM.

Activity Summary:
Despite advancements in diagnostics and therapeutics, Hypertrophic Cardiomyopathy (HCM) remains underdiagnosed and inconsistently managed across clinical settings. Clinicians often struggle to identify early signs of HCM, differentiate it from similar cardiac conditions, and apply evolving risk stratification tools and treatment strategies. Traditional therapies provide limited symptom relief and do not address the underlying pathophysiology, while the integration of newer disease-modifying agents such as Cardiac Myosin Inhibitors (CMIs) is still evolving in practice.

During this video series, Drs. Theodore Abraham and Martin Maron address these challenges aiming to improve the recognition, diagnosis, and management of HCM.

Activity Summary:
Pulmonary hypertension (PH) remains a serious and often underrecognized complication in patients with interstitial lung disease (ILD), significantly contributing to increased morbidity, mortality, and overall healthcare burden. Because of the clinical overlap between fibrotic lung disease and PH, early signs are frequently missed, leading to delays in diagnosis and limited opportunities for timely intervention. Evolving definitions and diagnostic criteria for PH further highlight the need to refine and update current screening approaches—especially for patients with early or borderline disease.

In this expert-led podcast, Dr. Nathan shares practical insights on recognizing early indicators of PH in the setting of ILD, interpreting key diagnostic findings, and applying effective risk stratification strategies. The discussion focuses on improving early detection and optimizing management to ultimately enhance outcomes for this high-risk patient population.

Activity Summary:
To further build on the insights presented in the Clinical Clips® in NF1-PN: Key Advances from AAN 2026 by Dr. Angela Hirbe, HCPs can access a range of downloadable resources designed to reinforce key concepts and support practical application in clinical care.

Available Resources:

Clinical Snippet Highlights: AAN 2026 Evidence at a Glance
A PDF summarizing each key presentation or poster featured in the Clinical Clip, with evidence-based takeaways for each study.

Downloadable Slide Deck (PDF)
Downloadable version of the presentation slides used by the faculty, including data visuals, figures, and key discussion points.

Expert Commentary Transcript
A transcript of the podcast version of the program, reflecting the expert discussion and interpretation of AAN 2026 data.

Discussion Guide: Applying Emerging NF1 Evidence Across the Lifespan
A brief guide with reflective questions and prompts related to patient selection, interpretation of outcomes beyond imaging, and longitudinal management considerations.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from the Advancing Myasthenia Gravis Care: Emerging Insights from AAN 2026 presented by Dr. James Howard Jr., HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Available Resources:

Clinical Snippet Highlights: AAN 2026 Evidence in Myasthenia Gravis
A summary highlighting each abstract, presentation, or poster discussed in the Clip, with key findings, clinical relevance, and practical takeaways.

Downloadable Slides
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Podcast Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Diagnostic and Severity Assessment Quick Reference
A reference guide summarizing diagnostic considerations, testing options, and commonly used severity assessment tools discussed in the program.

Emerging Treatment Landscape Overview
An overview outlining emerging treatment strategies covered in the Clip, including mechanisms of action and potential clinical considerations.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Leveraging emerging evidence presented at AAN, Dr. Angela Hirbe provides a synthesis of key findings, highlight their relevance across pediatric and adult care, and frames practical considerations for patient assessment and longitudinal management.

Activity Summary:
Clinical care for myasthenia gravis is entering a period of meaningful progress, with growing opportunities to improve how the disease is diagnosed, assessed, and treated. Increased awareness of disease heterogeneity and the expanding use of standardized severity assessments are helping clinicians better define disease burden and guide management decisions.

In this 20-minute podcast episode, Dr. James Howard Jr. provides comprehensive coverage of key MG presentations, scientific symposia, posters, and abstracts presented at AAN 2026.

Activity Summary:
PH is a serious and frequently underdiagnosed complication in patients with ILD, contributing to increased morbidity, mortality, and healthcare burden. The clinical overlap between fibrotic lung disease and PH often results in delayed recognition and missed opportunities for early intervention. Recent updates to PH definitions and diagnostic criteria underscore the importance of revising clinical screening strategies, particularly for patients with borderline or early-stage disease.

During this expert led video, Dr. Nathan presents key insights on identifying early signs of PH in ILD, interpreting relevant diagnostic data, and appropriately stratifying risk – aiming to improve diagnosis, management, and outcomes in this high-risk population.

Activity Summary:
Neurofibromatosis type 1 (NF1) treatment is evolving rapidly, with new data emerging across clinical trials and real-world studies. For busy clinicians, the challenge is not access to information, but quickly understanding what is clinically meaningful and how it should influence care.

This Clinical Clip from AAN 2026 delivers a focused, expert-led review of emerging NF1-PN treatment data in just 10-minutes. Designed for real-world practice, this concise update highlights key findings, clarifies their clinical relevance, and provides practical insights to support patient selection and treatment decisions.

Watch the clip to stay current, sharpen your clinical thinking, and translate new evidence into action.

Activity Summary:
Myasthenia gravis care is advancing quickly, with new evidence shaping how clinicians approach disease assessment and treatment selection. At the same time, variability in presentation, delays in diagnosis, and uncertainty around integrating emerging therapies continue to create challenges in clinical practice. Clinicians need concise, practical education that translates evolving data into clear and actionable strategies that can be applied in real-world care.

This focused Clinical Clip from AAN 2026 features Dr James (Chip) Howard, a leading expert in myasthenia gravis, delivering a 20-minute update on the most clinically relevant advances presented in Chicago. Designed for efficiency and practical application, this program highlights how to incorporate emerging therapies into individualized treatment plans to support confident, evidence-based decision-making.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" podcast episodes from data presented at CROI 2026.